Overview

A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Status:
Unknown status
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This is a first in man, Phase I safety study of Anginera in adults with Left Ventricular Dysfunction (LVD) and Reversible Myocardial Ischemia undergoing a CABG procedure.
Phase:
Phase 1
Details
Lead Sponsor:
Theregen, Inc.